Taixing Cui to Deubiquitinating Enzyme CYLD
This is a "connection" page, showing publications Taixing Cui has written about Deubiquitinating Enzyme CYLD.
Connection Strength
1.196
-
CYLD exaggerates pressure overload-induced cardiomyopathy via suppressing autolysosome efflux in cardiomyocytes. J Mol Cell Cardiol. 2020 08; 145:59-73.
Score: 0.693
-
Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2. J Mol Cell Cardiol. 2015 Jul; 84:143-53.
Score: 0.121
-
CYLD-mediated signaling and diseases. Curr Drug Targets. 2015; 16(4):284-94.
Score: 0.119
-
A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells. Biochem Biophys Res Commun. 2012 Mar 30; 420(1):78-83.
Score: 0.097
-
Tumor suppressor cylindromatosis: expressed in IgA nephropathy and negatively associated with renal tubulo-interstitial lesion. Chin Med J (Engl). 2009 Nov 05; 122(21):2603-7.
Score: 0.083
-
An emerging role of deubiquitinating enzyme cylindromatosis (CYLD) in the tubulointerstitial inflammation of IgA nephropathy. Biochem Biophys Res Commun. 2009 Dec 11; 390(2):307-12.
Score: 0.082